129 related articles for article (PubMed ID: 4626496)
1. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
Jennings WG
J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
[No Abstract] [Full Text] [Related]
2. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
Bazo AJ
J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
[No Abstract] [Full Text] [Related]
3. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
Rao DB; Norris JR
Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
[No Abstract] [Full Text] [Related]
4. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
Banen DM
J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
[No Abstract] [Full Text] [Related]
5. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
Teixeira JE
Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
[No Abstract] [Full Text] [Related]
6. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
[No Abstract] [Full Text] [Related]
7. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
Ditch M; Kelly FJ; Resnick O
J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
[No Abstract] [Full Text] [Related]
8. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
Lozeron H
Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
[No Abstract] [Full Text] [Related]
9. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
Hughes JR; Williams JG; Currier RD
J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
[TBL] [Abstract][Full Text] [Related]
10. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
11. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
Thibault A
Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
[No Abstract] [Full Text] [Related]
12. Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.
Rehman SA
Curr Med Res Opin; 1973; 1(8):456-62. PubMed ID: 4204089
[No Abstract] [Full Text] [Related]
13. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
Bochner F; Eadie MJ; Tyrer JH
J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
[No Abstract] [Full Text] [Related]
14. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
McConnachie RW
Curr Med Res Opin; 1973; 1(8):463-8. PubMed ID: 4204090
[No Abstract] [Full Text] [Related]
15. [On the encephalotrophic action of hydergine. Clinical study].
Garagnani Sciarretta B; Rimondini S; Martelli A
Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
[No Abstract] [Full Text] [Related]
16. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
Gerin J
Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
[No Abstract] [Full Text] [Related]
17. [Therapy of cerebral insufficiency].
Grill P; Broicher H
Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669
[No Abstract] [Full Text] [Related]
18. Hydergine for cerebral arteriosclerosis.
Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
[No Abstract] [Full Text] [Related]
19. [Wallerox increases cerebral circulation and heart capacity].
Heynen U
Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
[No Abstract] [Full Text] [Related]
20. [Sympatholytic vasodilator in cerebral circulation disorders].
Lipke PR
Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
